These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 12810646)

  • 21. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent.
    Zou W; Luo C; Zhang Z; Liu J; Gu J; Pei Z; Qian C; Liu X
    Oncogene; 2004 Jan; 23(2):457-64. PubMed ID: 14724574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter.
    Davis JJ; Wang L; Dong F; Zhang L; Guo W; Teraishi F; Xu K; Ji L; Fang B
    Cancer Gene Ther; 2006 Jul; 13(7):720-3. PubMed ID: 16485010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
    Li W; Tan J; Wang P; Li N; Li C
    Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy.
    Hu Z; Robbins JS; Pister A; Zafar MB; Zhang ZW; Gupta J; Lee KJ; Newman K; Yun CO; Guise T; Seth P
    Cancer Gene Ther; 2010 Apr; 17(4):235-43. PubMed ID: 19798122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase-dependent oncolytic adenovirus for cancer treatment.
    Huang TG; Savontaus MJ; Shinozaki K; Sauter BV; Woo SL
    Gene Ther; 2003 Aug; 10(15):1241-7. PubMed ID: 12858189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B
    Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
    Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
    Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
    Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.
    Zhao HC; Zhang Q; Yang Y; Lu MQ; Li H; Xu C; Chen GH
    World J Gastroenterol; 2007 Feb; 13(5):683-91. PubMed ID: 17278190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
    Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
    Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
    Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
    Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
    Fujiwara T; Urata Y; Tanaka N
    Curr Cancer Drug Targets; 2007 Mar; 7(2):191-201. PubMed ID: 17346111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer.
    Onimaru M; Ohuchida K; Nagai E; Mizumoto K; Egami T; Cui L; Sato N; Uchino J; Takayama K; Hashizume M; Tanaka M
    Cancer Lett; 2010 Aug; 294(2):178-86. PubMed ID: 20163915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers.
    Wang X; Su C; Cao H; Li K; Chen J; Jiang L; Zhang Q; Wu X; Jia X; Liu Y; Wang W; Liu X; Wu M; Qian Q
    Mol Cancer Ther; 2008 Jun; 7(6):1598-603. PubMed ID: 18566230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.
    Su CQ; Wang XH; Chen J; Liu YJ; Wang WG; Li LF; Wu MC; Qian QJ
    World J Gastroenterol; 2006 Dec; 12(47):7613-20. PubMed ID: 17171789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
    Ito H; Aoki H; Kühnel F; Kondo Y; Kubicka S; Wirth T; Iwado E; Iwamaru A; Fujiwara K; Hess KR; Lang FF; Sawaya R; Kondo S
    J Natl Cancer Inst; 2006 May; 98(9):625-36. PubMed ID: 16670388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.